Comparison of docetaxel- and vinca alkaloid-based chemotherapy in the first-line treatment of advanced non-small cell lung cancer: a meta-analysis of seven randomized clinical trials.
about
Optimizing the management of advanced non-small-cell lung cancer: a personal viewVeriStrat classifier for survival and time to progression in non-small cell lung cancer (NSCLC) patients treated with erlotinib and bevacizumab.Future scenarios for the treatment of advanced non-small cell lung cancer: focus on taxane-containing regimens.Comparing effectiveness with efficacy: outcomes of palliative chemotherapy for non-small-cell lung cancer in routine practice.Efficacy and safety of docetaxel for advanced non-small-cell lung cancer: a meta-analysis of Phase III randomized controlled trials.A randomized phase III trial of oral S-1 plus cisplatin versus docetaxel plus cisplatin in Japanese patients with advanced non-small-cell lung cancer: TCOG0701 CATS trial.A phase Ia/Ib clinical trial of metronomic chemotherapy based on a mathematical model of oral vinorelbine in metastatic non-small cell lung cancer and malignant pleural mesothelioma: rationale and study protocol.Prediction of survival benefits from progression-free survival benefits in advanced non-small-cell lung cancer: evidence from a meta-analysis of 2334 patients from 5 randomised trials.Overall survival should be the primary endpoint in clinical trials for advanced non-small-cell lung cancer.Improving Outcomes in Advanced Lung Cancer: Maintenance therapy in non-small-cell lung carcinoma.Tumor cell expression of vascular endothelial growth factor receptor 2 is an adverse prognostic factor in patients with squamous cell carcinoma of the lungConcomitant etoposide and cisplatin provided improved survival compared with docetaxel and cisplatin in patients with locally advanced non-small cell lung cancer treated with chemoradiotherapy.Vinorelbine for non-small cell lung cancer.An evaluation of the pharmacokinetics and clinical use of vinorelbine for NSCLC treatment.Tubulin inhibitors in non-small cell lung cancer: looking back and forward.Emerging treatment using tubulin inhibitors in advanced non-small cell lung cancer.A multi species evaluation of the radiation dosimetry of [11C]erlotinib, the radiolabeled analog of a clinically utilized tyrosine kinase inhibitor.A call for the aggressive treatment of oligometastatic and oligo-recurrent non-small cell lung cancer.Sequential chemoradiotherapy with accelerated hypofractionated radiotherapy compared to concurrent chemoradiotherapy with standard radiotherapy for locally advanced non-small cell lung cancer.
P2860
Q24656144-7772484F-0E7B-48FB-9976-DEA055E8390CQ33937644-332FF6C4-5C6C-4054-B0AA-E6421B69386DQ35583723-96FBD662-26B4-471A-A2B3-DCCB41BC3878Q35714504-20FA0AAB-6545-4CA2-BD19-AE6D2DEE5C80Q35766183-893B879C-7F78-42BA-8BCD-06BBE9E64CE4Q35775244-0A1A1870-FBB5-4B38-BECD-C6D8EABF7374Q35994241-03CB7DE0-BBF3-493D-928F-F08098479191Q36730313-1B80DB5D-F63D-4234-AAF9-EF2C16B370EFQ36738554-6C80B658-7C72-4F1A-A7E4-A9C24A17BDCAQ36741073-ED38B8F6-047D-4ED2-A87C-7CE64FEE8A97Q37308766-71F08979-B14A-4CEC-85EA-9AE8060C18A1Q37605623-744E1467-F0C7-43D8-9632-01C188148D5FQ37720767-39CB9CE6-F602-45D4-B505-796AA786A571Q38109229-64E2470C-7839-429F-B9E9-12579C631B3BQ38742506-836A7865-19EC-49E7-B090-44E2E36415CFQ38847914-15338E11-ED9F-4315-A65A-7BF00E898190Q38996621-22146D6F-C9E8-4122-BC29-3ABDB4B65E66Q41645384-96D554D6-9039-45F7-9C7F-257C1FC44864Q43561521-C279F877-DF8E-4B5C-9315-7F700FEED5BD
P2860
Comparison of docetaxel- and vinca alkaloid-based chemotherapy in the first-line treatment of advanced non-small cell lung cancer: a meta-analysis of seven randomized clinical trials.
description
2007 nî lūn-bûn
@nan
2007 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
name
Comparison of docetaxel- and v ...... en randomized clinical trials.
@ast
Comparison of docetaxel- and v ...... en randomized clinical trials.
@en
Comparison of docetaxel- and v ...... en randomized clinical trials.
@nl
type
label
Comparison of docetaxel- and v ...... en randomized clinical trials.
@ast
Comparison of docetaxel- and v ...... en randomized clinical trials.
@en
Comparison of docetaxel- and v ...... en randomized clinical trials.
@nl
prefLabel
Comparison of docetaxel- and v ...... en randomized clinical trials.
@ast
Comparison of docetaxel- and v ...... en randomized clinical trials.
@en
Comparison of docetaxel- and v ...... en randomized clinical trials.
@nl
P2093
P1476
Comparison of docetaxel- and v ...... en randomized clinical trials.
@en
P2093
Alain Monnier
Jaime Ernesto Rubio
Jean-Louis Pujol
Kaoru Kubota
Michel Cucherat
Shinzoh Kudoh
Silvy Laporte
Vassilis Georgoulias
P304
P356
10.1097/JTO.0B013E318153FA2B
P577
2007-10-01T00:00:00Z